Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Lubisch; Wilfried
Address:
Mannheim, DE
No. of patents:
25
Patents:












Patent Number Title Of Patent Date Issued
6436949 Heterocyclically substituted benzamides and their use August 20, 2002
Heterocyclically substituted benzamides of the formula I ##STR1##are described, where R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, X, m and n have the meanings given in the description. The novel compounds are useful for controlling diseases.
6414157 3-Substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their July 2, 2002
3-substituted tetrahydropyridopyrimidinone derivatives of the formula (I) wherein the radicals have the meanings given in the Description, to a method for producing said derivatives and, to their use for producing active ingredients for drugs. ##STR1##
6407109 Pyrrolyl tetrahydroquinoxalin diones, their production and use in the treatment of diseases June 18, 2002
Pyrrolylquinoxalinediones of the formula I ##STR1##and their tautomeric and isomeric forms, and their physiologically tolerated salts, where the variables have the following meanings:R.sup.1hydrogen, cyclohexylan aliphatic radical which has 1 to 4 carbon atoms and can carry the radical -
6380220 Derivatives from piperidine-keto acid, their preparation and use April 30, 2002
Piperidineketocarboxylic acid derivatives of the general formula I ##STR1##and their tautomeric and isomeric forms, and physiologically tolerable salts thereof, where the variables have the meanings given in the description, preparation of these compounds and their use as drugs.
6346622 2-substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-HT1A, 5H February 12, 2002
##STR1##where the substituents have the meanings indicated in the description, their preparation and use as serotonin antagonists.
6277850 Pyrrolyl quinoxalindiones their production and use as AMPA receptor antagonists August 21, 2001
Pyrrolylquinoxalinediones of the formula I ##STR1##and their tautomeric and isomeric forms, and their physiologically tolerated salts are described, where the variables have the following meaning:R.sup.1 hydrogen, C.sub.1 -C.sub.6 -alkyl, substituted by hydroxyl or carboxyl,R.sup.2 h
6251917 Benzamidoaldehydes and their use as cysteine protease inhibitors June 26, 2001
Compounds of the formula ##STR1##where R.sup.1, R.sup.2, R.sup.3, X and n are as defined in the description, are inhibitors of cysteine protease.
6222034 3-substituted pyrido[4',3':4,5]thieno[2,3-d]pyrimidine derivatives, their preparation and their April 24, 2001
A 3-substituted 3,4,5,6,7,8-hexahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidine compound of formula I ##STR1##whereinR.sup.1 is hydrogen, C.sub.1 -C.sub.4 -alkyl, acetyl or benzoyl, optionally substituted phenyl-C.sub.1 -C.sub.4 -alkyl, naphthyl-C.sub.1 -C.sub.3 -alkyl, phenyl-C.su
6172072 Heterocyclically substituted benzamides and their use in fighting diseases January 9, 2001
Heterocyclically substituted benzamides of the formula I ##STR1##are described, where R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, X, m and n have the meanings given in the description. The novel compounds are useful for controlling diseases.
6121265 Heterocyclic substituted imidazoloquinoxalinones, their preparation and their use September 19, 2000
Imidazoloquinoxalinones of the formula ##STR1## where R.sup.1 -R.sup.5, A and B have the meanings stated in the description, and their preparation are described. The novel substances are suitable for controlling diseases.
6103720 Ketobenzamides as calpain inhibitors August 15, 2000
The patent describes ketobenzamides of the formula ##STR1## where R1, R2, R3, R4, X and n have the meanings given in the description, and their preparation. The novel compounds are useful for controlling disorders.
5852017 2,3(1H,4H)-quinoxalinediones December 22, 1998
2,3(1H,4H)-quinoxalinediones of the formula I ##STR1## where R.sup.1 is hydrogen, an aliphatic radical which has up to 12 carbons and can be substituted by one of the following: phenyl, cyclopentyl, cyclohexyl or --CO--R.sup.3, --CO--O--R.sup.3 or --CO--NH--R.sup.3, where R.sup.3
5849744 Pyrrolyl tetrahydrobenzoquinoxaline diones, their preparation and use as glutamate receptor anta December 15, 1998
Pyrrolyltetrahydrobenzoquinoxalinediones of the formula I ##STR1## and their tautomeric and isomeric forms, and their physiologically tolerated salts, in which the variables have the meanings stated in the description, and the preparation thereof are described. The novel compound
5849743 Quinoxalines and drugs prepared therefrom December 15, 1998
Quinoxaline-2,3-(1H,4H)-diones of the formula I ##STR1## and their tautomeric and enantiomeric forms and their physiologically tolerated salts, the variables R, R.sup.1 and R.sup.2 have the meanings specified in claim 1, and are useful for therapeutic treatment of neurodegenerati
5773439 Amido-quinoxalinediones, the preparation and use thereof June 30, 1998
Novel amido-quinoxalinediones of the formula ##STR1## where R.sup.1 -R.sup.5, n and m have the meanings stated in the description, and the preparation thereof are described. The compounds are suitable for controlling diseases.
5714489 2,3(1H,4H)quinoxalinedione February 3, 1998
2,3(1H,4H)-quinoxalinediones of the formula I ##STR1## where R.sup.1 is hydrogen, an aliphatic radical which has up to 12 carbons and can be substituted by one of the following: phenyl, cyclopentyl, cyclohexyl or --CO--R.sup.3, --CO--O--R.sup.3 or --CO--NH--R.sup.3, where R.sup.3
5296485 Substituted N-phenylpiperidines and drugs therefrom March 22, 1994
Substituted N-phenylpiperidines I ##STR1## (R.sup.1 =H, NO.sub.2, CN, halogen, C.sub.1 -C.sub.4 -alkyl, CF.sub.3, OCF.sub.3, OH, CH.sub.2 OH, COOH, CHO, NH--CHO, NH.sub.2, CO--NH.sub.2, 5-tetrazinyl, R.sup.4 --O--, R.sup.4 --O--CH.sub.2 --, R.sup.4 O--CO--, R.sup.4 --CO--, R.sup.
5270325 P-hydroxy phenone derivatives used in the treatment of cardiac arrhythmia December 14, 1993
p-hydroxy phenone derivatives of the formula I ##STR1## where X is ##STR2## where R.sup.1 =F, Cl, Br or trifluoromethyl or a heteroaryl of the structure ##STR3## with R.sup.2 =C.sub.1 -C.sub.4 -alkyl,Y is a bridging member of the formula --CH.dbd.CH--, --CH.sub.2 CH.sub.2
5260330 Substituted anilides November 9, 1993
Substituted anilides of the formula I ##STR1## (where R.sup.1 is C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -haloalkyl, C.sub.1 -C.sub.4 -alkoxy, halogen, cyano, nitro, C.sub.2 -C.sub.4 -alkenyl, C.sub.2 -C.sub.4 -alkynyl;X is methylene, ethylene, vinylene;R.sup.2 and R.sup.3 are each
5260318 Phenylpiperidylamines and drugs containing them November 9, 1993
Phenylpiperidylamines of the formula I ##STR1## R.sup.1 is H, NO.sub.2, R.sup.4 SO.sub.2 NH, ##STR2## N.dbd.C, CF.sub.3, CF.sub.3 O, F, Cl, Br, C.sub.1 -C.sub.4 -alkyl, R.sup.3 O, CO.sub.2 R.sup.3, CHO, CH.dbd.NOR.sup.3, CH.sub.3 OR.sup.3 andR.sup.2 is H, F, Cl, Br, C.sub.1 -C.s
5175174 Phenylpiperidinylamines and drugs containing these December 29, 1992
Phenylpiperidinylamines of the formula I ##STR1## where R.sup.1 is --NHSO.sub.2 R.sup.4 or ##STR2## R.sup.2 and R.sup.3 are each, independently of one another, H or C.sub.1 -C.sub.4 -alkyl or together are a (CH.sub.2).sub.n chain with n=4 or 5, andR.sup.4 is C.sub.1 -C.sub.4
5118682 p-Hydroxy phenone derivatives and the use thereof June 2, 1992
p-Hydroxy phenone derivatives of the general formula I ##STR1## where R.sup.1, R.sup.2 and R.sup.3 are identical or different and are methyl, chlorine, bromine and hydrogen, but R.sup.1, R.sup.2 and R.sup.3 are not all H,R.sup.4 and R.sup.5 are identical or different and are H, C.sub
5055475 P-hydroxy phenone derivatives and drugs containing these October 8, 1991
P-hydroxy phenone derivatives of the formula 1 ##STR1## where X is ##STR2## where R.sup.1 =F, Cl, Br or trifluoromethyl or a heteroaryl of the structure ##STR3## with R.sup.2 =C.sub.1 -C.sub.4 - alkyl,Y is a bridging member of the formula --CH.dbd.CH--, --CH.sub.2 CH.sub.
4980361 P-hydroxy phenone derivatives and drugs containing these December 25, 1990
Abstract of the disclosure: p-hydroxy phenone derivatives of the formula I ##STR1## where X is ##STR2## where R.sup.1 =F, Cl, Br or trifluoromethyl or a heteroaryl of the structure ##STR3## with R.sup.2 =C.sub.1 -C.sub.4 -alkyl, Y is a bridging member of the formula -
4959373 Bispidine derivatives as class III antiarrhythmic agents September 25, 1990
Bispidine derivatives of the formula I ##STR1## where R, R.sup.1 and R.sup.3 are identical or different and are each H, C.sub.1 -C.sub.4 -alkyl, halogen or C.sub.1 -C.sub.4 -alkoxy, when Y is ##STR2## R.sup.2 is C.sub.1 -C.sub.4 -alkyl, halogen, --CN, C.sub.1 -C.sub.4 -alkoxy










 
 
  Recently Added Patents
Positive active material and positive electrode for rechargeable lithium battery and rechargeable lithium battery including the positive electrode
Feature set embedding for incomplete data
Flat panel display device and method of manufacturing the same
Duplex web printer system registration technique
Retainer
Methods for making polyglycerol
Method and apparatus for preserving virtual desktops for e-discovery through an agent-less solution
  Randomly Featured Patents
Dial gage
Method for treating hyperglycemia in mammals using arylamino benzoic acids
Phase frequency detecting circuit
Portable media player recommendation system
Plant pot
Temperature-compensated dispensing of compressed gases
Radio communication apparatus capable of switching modulation schemes
Modular, high-throughput air treatment system
Optical disk having virtually constant width recording track and optical disk apparatus
Carton with a dispenser in the top panel for dispensing pouches